Head to head
Trinity vs Q-Plus C EVO (2026)
Compare purchase costs, running costs and the evidence behind each device.
Read the comparison overview
- Purchase cost
- Catalog new-price ranges: Trinity, $100k–$130k; Q-Plus C EVO, $80k–$110k. Check the source notes and request current quotes.
- FDA status
- No US 510(k) clearance has been located for the Trinity. Q-Plus C EVO holds FDA 510(k) clearance for its marketed indication.
- Practice fit
- Both are listed under q-switched tattoo/pigment. Check each model’s US regulatory status and labeled indications for your intended use.
Q-Switched Tattoo/Pigment
View full device profile →Q-Switched Tattoo/Pigment
View full device profile →Price comparison
New price range
- Astanza Trinity
- $100k–$130kSource not documented
- Quanta System Q-Plus C EVO
- $80k–$110kSource not documented
Used asking range
- Astanza Trinity
- $55k–$80kSource not documented
- Quanta System Q-Plus C EVO
- $45k–$70kSource not documented
Payback calculator
- Astanza Trinity
- View ROI calculator
- Quanta System Q-Plus C EVO
- View ROI calculator
Next step
Consumable economics
Consumable cost / lock-in
- Astanza Trinity
- —
- Quanta System Q-Plus C EVO
- —
Service cost
- Astanza Trinity
- Not published
- Quanta System Q-Plus C EVO
- Not published
FDA clearance
FDA status & indication
- Astanza Trinity
- No US 510(k) located
- Quanta System Q-Plus C EVO
Read FDA indication wording
“The EVO Platform is intended for use in aesthetic, cosmetic and surgical applications requiring incision, excision, ablation, vaporization and coagulation of body soft tissues in the medical specialties of dermatology, general, plastic and oral surgery as follows. 1064 & 532 nm (Q-Switched, nanosecond mode) The EVO Platform is intended for treatment of vascular lesions, pigmented lesions, and for hair, tattoo removal and the incision, excision, ablation, vaporization of soft tissue for General dermatology such as, but not limited to treatment of: 532 nm (Q-Switched, nanosecond mode) Removal of light ink (red, sky blue, green, tan, purple, and orange) tattoos Treatment of vascular lesions including, but not limited to: - port wine birthmarks - telangiectasias - spider angiomaa - Cherry angioma - Spider nevi Treatment of benign pigmented lesions including, but not limited to: - cafe-au-Iait birthmarks - Ephalides, solar lentigines - senile lentigines - Becker's nevi - freckles - common nevi - nevus spilus - Ota Nevus Treatment of seborrheic keratosis Treatment of post inflammatory hyperpigmentation Skin resurfacing procedures for the treatment of acne scars and wrinkles.”
Which chains run each
Chain adoption
- Astanza Trinity
- 0 recorded pairings
- Quanta System Q-Plus C EVO
- 0 recorded pairings
Chains using it
- Astanza Trinity
- —
- Quanta System Q-Plus C EVO
- —
Approved reviews
- Astanza Trinity
- 0
- Quanta System Q-Plus C EVO
- 0
Specs and platform
Manufacturer
- Astanza Trinity
- Astanza
- Quanta System Q-Plus C EVO
- Quanta System
Built by (OEM)
- Astanza Trinity
- Astanza Laser LLC
- Quanta System Q-Plus C EVO
- Quanta System S.p.A.
Category
- Astanza Trinity
- Q-Switched Tattoo/Pigment
- Quanta System Q-Plus C EVO
- Q-Switched Tattoo/Pigment
Technology
- Astanza Trinity
- QS Nd:YAG + QS ruby combo (Nd:YAG)
- Quanta System Q-Plus C EVO
- QS Nd:YAG + ruby (+alex option) (Nd:YAG)
Launch year
- Astanza Trinity
- 2016
- Quanta System Q-Plus C EVO
- 2019
Status
- Astanza Trinity
- Current
- Quanta System Q-Plus C EVO
- Current
Manufacturer source record
- Astanza Trinity
- No linked source on file.
- Quanta System Q-Plus C EVO
- No linked source on file.
Current alternatives
Current catalog models in related categories. Confirm availability and configuration with the supplier.
Device and company names are trademarks of their respective owners. The Aesthetic Index is not affiliated with or endorsed by any manufacturer, distributor or lender named here, except as disclosed. Price figures are references, not current offers. Check each device’s source notes. Not medical, legal or regulatory advice.